GLUT2 Accumulation in Enterocyte Apical and Intracellular Membranes
Open Access
- 16 September 2011
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (10), 2598-2607
- https://doi.org/10.2337/db10-1740
Abstract
OBJECTIVE: In healthy rodents, intestinal sugar absorption in response to sugar-rich meals and insulin is regulated by GLUT2 in enterocyte plasma membranes. Loss of insulin action maintains apical GLUT2 location. In human enterocytes, apical GLUT2 location has not been reported but may be revealed under conditions of insulin resistance. RESEARCH DESIGN AND METHODS: Subcellular location of GLUT2 in jejunal enterocytes was analyzed by confocal and electron microscopy imaging and Western blot in 62 well-phenotyped morbidly obese subjects and 7 lean human subjects. GLUT2 locations were assayed in ob/ob and ob/+ mice receiving oral metformin or in high-fat low-carbohydrate diet–fed C57Bl/6 mice. Glucose absorption and secretion were respectively estimated by oral glucose tolerance test and secretion of [U-14C]-3-O-methyl glucose into lumen. RESULTS: In human enterocytes, GLUT2 was consistently located in basolateral membranes. Apical GLUT2 location was absent in lean subjects but was observed in 76% of obese subjects and correlated with insulin resistance and glycemia. In addition, intracellular accumulation of GLUT2 with early endosome antigen 1 (EEA1) was associated with reduced MGAT4a activity (glycosylation) in 39% of obese subjects on a low-carbohydrate/high-fat diet. Mice on a low-carbohydrate/high-fat diet for 12 months also exhibited endosomal GLUT2 accumulation and reduced glucose absorption. In ob/ob mice, metformin promoted apical GLUT2 and improved glucose homeostasis. Apical GLUT2 in fasting hyperglycemic ob/ob mice tripled glucose release into intestinal lumen. CONCLUSIONS: In morbidly obese insulin-resistant subjects, GLUT2 was accumulated in apical and/or endosomal membranes of enterocytes. Functionally, apical GLUT2 favored and endosomal GLUT2 reduced glucose transepithelial exchanges. Thus, altered GLUT2 locations in enterocytes are a sign of intestinal adaptations to human metabolic pathology.Keywords
This publication has 47 references indexed in Scilit:
- Detection of extracellular glucose by GLUT2 contributes to hypothalamic control of food intakeAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Hematopoietic Cell-Specific Deletion of Toll-like Receptor 4 Ameliorates Hepatic and Adipose Tissue Insulin Resistance in High-Fat-Fed MiceCell Metabolism, 2009
- The Glucose Transporter 2 Undergoes Plasma Membrane Endocytosis and Lysosomal Degradation in a Secretagogue-Dependent MannerEndocrinology, 2009
- GLUT7: a new intestinal facilitated hexose transporterAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Inhibition of the intestinal glucose transporter GLUT2 by flavonoidsThe FASEB Journal, 2006
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Insulin Receptor (IR) and Glucose Transporter 2 (GLUT2) Proteins Form a Complex on the Rat Hepatocyte MembraneCellular Physiology and Biochemistry, 2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Obesity and insulin resistanceJCI Insight, 2000